Upc2p-associated differential protein expression in Candida albicans

Area of Science:

• Medical Mycology
• Molecular Biology
• Proteomics

Background:

• The gain-of-function mutation G648D in UPC2 is known to up-regulate ERG11 and increase fluconazole resistance in Candida albicans.
• Understanding the proteomic changes associated with this mutation is crucial for developing new antifungal strategies.

Purpose of the Study:

• To identify proteomic alterations in a fluconazole-resistant Candida albicans clinical isolate overexpressing ERG11 compared to its susceptible parent strain.
• To determine which of these differentially expressed proteins are regulated by the UPC2 G648D mutation.

Main Methods:

• Two-dimensional gel electrophoresis (2-DE) was used to separate proteins.
• Peptide mass fingerprinting (PMF) was employed for protein identification.
• Proteomic analysis was conducted on a clinical isolate and its parent strain, as well as a wild-type strain with the mutated UPC2 allele.

Main Results:

• Twenty-three differentially expressed proteins were identified between the resistant and susceptible strains.
• Seven of these proteins also showed differential expression in a wild-type strain after introducing the mutated UPC2 allele.
• This suggests a direct regulatory role of the UPC2 G648D mutation on these seven proteins.

Conclusions:

• The UPC2 G648D mutation significantly alters the proteome of Candida albicans, leading to increased fluconazole resistance.
• Upc2p-regulated proteins identified in this study are potential contributors to antifungal resistance.
• Further investigation into these proteins could reveal novel therapeutic targets for combating Candida albicans infections.